Online Conference Center

                                                                            Vaccination News    

Breaking News Archives - each day's breaking news from December 1, 2003 (check here for breaking news you might have missed and breaking news that didn't ever hit the "front page")

More News - all the news most recently posted on this website

All the News - a running tab of everything posted on this website since October 29, 2003

Top Stories Archives - daily breaking and other important news stories

Daily News Archives - all the news posted on this website each day (from April 2001)

Hot Topics - selected stories, by category

Return to Vaccination News Home Page (for best results, right click to "open in new window")

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

click here to download Adobe Reader    click here for Picks of the Week    click here for the old "Recommended List"

http://www.icondata.com/health/pedbase/files/HENOCH-S.HTM

Note: This can be vaccine-induced. - SM

  • Pediatric Database (PEDBASE)
  • Discipline: RHE
  • Last Updated: 6/05/94
  •  

    HENOCH-SCHOENLEIN PURPURA

     

    DEFINITION:

    A vasculitic syndrome of small vessels classically characterized by a purpuric rash, abdominal pain, arthritis, and nephritis.

    EPIDEMIOLOGY:

    PATHOGENESIS:

    1. Background

    2. Antigenic Stimulants

    1. Allergens

    2. Post-Infectious

    3. Post-Vaccination

    PATHOLOGY:

    1. Mechanism of Vasculitis

    CLINICAL FEATURES:

    1. Classical Features

    2. Cutaneous Manifestations

    1. Classic Rash (100%)

    1. Classic Lesion

    • urticarial wheals, erythematous maculopapules and/or larger palpable ecchymotic-looking lesions
    • appear on lower extremities and buttocks
    • may involve upper extremities, face, and trunk

    2. Petechiae or Purpura Lesions

    • evolve from red to purple -> rust-coloured with brownish hue -> fade
    • as new crops arise may give a polymorphic appearance
    • may be pruritic

    3. Erythema Multiforme

    • various forms - central hemorrhage or ulceration with bullae formation

    4. Angioedema

    • of extremities (46%) and scalp (20%)
    • nonpitting involving eyelids, lips, dorsa of hands and feet, back, perineum

    5. Others

    • vesicular eruptions
    • swelling and tenderness of an entire limb

    3. Rheumatologic Manifestations

    1. Arthritis/Arthralgia (68-75%)

    4. Gastrointestinal Manifestations

    1. Abdominal Pain (35-85%)

    2. Bloody Stool

    3. Intussusception (2-3%)

    4. Others

    5. Renal Manifestations

    1. Range of Renal Manifestations

    1. Hematuria

    • microscopic with proteinuria <2g/d
    • preserved renal function
    • a mild form of renal disease which does not evolve into end-stage renal disease

    2. Nephritic Syndrome

    • hematuria with hypertension, azotemia, and oliguria
    • proteinuria
    • 15% develop end-stage renal disease (ESRD)

    3. Nephrotic Syndrome

    • urinary protein excretion >40 mg/m2/hr
    • 50% of patients with both nephrotic and nephritic syndromes develop ESRD within 10 years of onset

    2. Other GU Manifestations

    1. Extrarenal

    1. Scrotal Swelling (2-35%)
    • associated with inflammation and hemorrhage of testes, appendix testes, spermatic cord, epi-didymis or scrotal wall
    • true torsion develops rarely

    2. Renal

    • bladder wall hematoma
    • calcified ureter
    • hydronephrosis
    • urethritis

    6. Neurological Manifestations

    1. Central Nervous System (uncommon)

    1. Headaches

    • most common CNS symptom

    2. Altered Mental Status

    • apathy, hyperactivity, irritability, mood lability, somnolence

    3. Seizures

    • partial, complex partial, generalized, status

    4. Focal Deficits

    • aphasia, ataxia, chorea, cortical blindness, hemiparesis, paraparesis, quadriparesis

    2. Peripheral Nervous System (rare)

    1. Polyradiculoneuropathies

    • brachial plexus neuropathy, Guillian-Barre syndrome

    2. Mononeuropathies

    • facial nerve, femoral nerve, peroneal nerve, sciatic nerve, ulnar nerve

    7. Hematologic Manifestations

    1. Hemorrhagic Diathesis

    INVESTIGATIONS:

    1. Serum

    2. Urinalysis

    3. Imaging Studies

    4. Biopsies

    1. Skin

    2. Renal

    • % of Glomeruli with Cresents (Frequency of Renal Failure)
    • <50 (4%)
    • 50-75 (25%)
    • >75 (67%)
    • 100 (100%)

    MANAGEMENT:

    Renal Failure

    1. Supportive

    1. Acute

    2. Long Term

    1. Clinical

    • cutaneous, rheumatoid, gastrointestinal, renal, and neurological manifestations

    2. Investigations

    • CBC, electrolytes, BUN, creatinine, albumin, amylase, urinalysis, stool for occult blood
    • seek immediate medical attention for
      • sudden onset of severe abdominal pain, distension, or bleeding
      • hemoptysis (breathing up blood)
      • seizures, personality changes, focal deficits, peripheral neuropathies

    2. Medications

    1. NSAID's

    2. Corticosteroids

    1. Prednisone

    • 1-2 mg/kg/day for 5-7 days
    • indications:
      • greater than 50% cresents on renal biopsy
      • abdominal colic or GI hemorrhage
      • soft tissue swelling
      • scrotal swelling
      • neurologic manifestations
      • intrapulmonary hemorrhage
    • not recommended for:
      • rash
      • joint pain

    3. Nephropathy

    1. Supportive

    2. Experimental

    4. Prognosis

    1. Excellent

    2. Poor

    Return to Vaccination News Home Page (for best results, right click to "open in new window")

    DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.